print ISSN: 2411-3956
Influence of diffuse and nodular adenomyosis on women's reproductive function
##common.pageHeaderLogo.altText## Actual Questions of Modern Gynecology and Perinatology

Abstract

In the course of studying this study, a comprehensive clinical, laboratory and instrumental prospective examination was carried out on 224 patients aged 30 to 50 years (average age – 42,0±1,8 years) with adenomyosis. The control group consisted of 84
women of relatively healthy reproductive age, with a regular ovulatory menstrual cycle and without a history of gynecological diseases. The conducted studies found that the largest group consists of patients aged 36-40 years - in the main group - 92
women, 41,1±3,3%, and in the control group - 37 women, which amounted to 44,0±5,4%.
The conducted studies have established that the absence of criteria for early diagnostics of adenomyosis leads to delays and difficulties in diagnostics. During the analysis of available medical documents, it was shown that there is an average of 5.3±1.8 years of "delay" in collecting anamnesis on the appearance of the first symptoms of the disease and making the correct diagnosis. At the same time, our studies have shown that a more thorough collection of anamnesis is necessary, the interpretation of dysmenorrhea in adolescence and pain syndrome and its severity on a visual analogue scale in women of early reproductive age, as well as the presence and severity of nonmenstrual pain should be approached more carefully. All this will also contribute to timely diagnostics.

References

Dessouky, R. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy / R. Dessouky, S. A. Gamil, M.G. Nada [et al.] // Insights Imaging. – 2019. Vol.10, № 1. P. 48.

Donnez, O., Donnez J. Gonadotropin-releasing hormone antagonist (linzagolix): A new therapy for

uterine adenomyosis. // Fertil. Steril. 2020;114:640-645.

Zakharenko, N.F. Clinical case report: conservative treatment of nodular adenomyosis. / N.F.Zakharenko, N.V. Kovalenko, Manoliak I.P. // Womens Health. 2019;8(2):150-152.

Harada, T. The Impact of Adenomyosis on Women's Fertility. // T. Harada, Y.M. Khine, А.Kaponis // Obstet Gynecol Surv. 2016;71(9):557-68.

Hashimoto, A. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition. / A.Hashimoto, T.Iriyama, S.Sayama [et al] //J Matern Fetal Neonatal Med. 2018;31(3):364-9.

Mahmoud, A., Khalifa, M.D. Adenomyosis as a confounder to accurate endometrial cancer staging. // Semin Ultrasound CT MRI. 2019;40(8):358–363.

Osada, H. Uterine adenomyosis and adenomyoma: the surgical approach // Fertil Steril. 2018;109(3):406-17.

Szubert, M. Adenomyosis and Infertility-Review of Medical and Surgical Approaches / M.Szubert, E.Koziróg, O.Olszak // Int. J. Environ. Res. Public Health. 2021; 18:1235

PDF (Azərbaycanca)
PDF (Azərbaycanca)

Keywords

adenomioz, diffuz forma, düyünlü forma, diaqnoz, sonsuzluq, uşaqlıq, differensial diaqnoz adenomyosis, diffuse form, nodular form, diagnosis, infertility, uterus, differential diagnostics аденомиоз, диффузная форма, узловатая форма, диагностика, бесплодие, матка, дифференциальная диагностика